Time-Resolved Network Entropy Analysis Identifies a CTNND1–VAV3 Subnetwork in Gefitinib-Resistant NSCLC
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188409 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Dimitra C Tsakona und 1 weiteren Autor:innen. Beteiligte Einrichtung: Inter-Faculty Program on Networks and Complexity, Aristotle University of Thessaloniki, 54124 Thessaloniki, Macedonia, Greece. Hauptthemen laut MEDLINE: Gefitinib, Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Catenins. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Touro College.
Abstract (Originalsprache)
Acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors remains the principal barrier to durable responses in non-small cell lung cancer (NSCLC), yet how the molecular interaction networks underlying this resistance reorganize over time is poorly understood. We reasoned that a systems-level signature of resistance should be visible in the way protein interaction networks remodel under sustained drug exposure, and therefore applied time-resolved network analysis to isogenic gefitinib-sensitive PC9 and gefitinib-resistant PC9R cells across 24 h of gefitinib treatment, computing network entropy and centrality measures for temporal protein interaction networks and interrogating co-expression-augmented networks for candidate resistance-associated bottleneck proteins. Network entropy rose in both phenotypes, indicating that entropic remodeling is a general response to EGFR pathway perturbation rather than a signature of resistance. In contrast, eigenvector entropy was higher in resistant cells at the earliest post-treatment time point, and resistant cells preserved giant-component connectivity and small-world topology early before fragmenting later. Temporal centrality analysis nominated BIRC3 as a resistant-cell-associated high-centrality node at 24 h, and co-expression analysis identified delta-catenin (CTNND1) as a high-betweenness bottleneck in the PC9R network, topologically bridging EGFR, VAV3, HIF3A, and NOTCH2. These findings nominate early post-treatment eigenvector entropy and a CTNND1-centered, EGFR-enriched subnetwork as candidate resistance-associated features that require validation in independent datasets and functional models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inter-Faculty Program on Networks and Complexity, Aristotle University of Thessaloniki, 54124 Thessaloniki, Macedonia, Greece.
- Department of Biology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Macedonia, Greece.
- Department of Basic Sciences, Touro College of Osteopathic Medicine, Touro University, New York, NY 10027, USA.
- Laboratory of Biological Chemistry, Aristotle University of Thessaloniki School of Medicine, 54124 Thessaloniki, Macedonia, Greece.
- Akesis Synergy Med, 49 Arkadiou Str., 56121 Thessaloniki, Macedonia, Greece.
Förderung
- Touro College
Zitieren
APA
Tsakona, D. C., & Papanikolaou, N. A. (2026). Time-Resolved Network Entropy Analysis Identifies a CTNND1–VAV3 Subnetwork in Gefitinib-Resistant NSCLC. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188409
Vancouver
Tsakona DC, Papanikolaou NA. Time-Resolved Network Entropy Analysis Identifies a CTNND1–VAV3 Subnetwork in Gefitinib-Resistant NSCLC. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188409
BibTeX
@article{Tsakona2026,
author = {Tsakona, Dimitra C and Papanikolaou, Nikolaos A},
title = {Time-Resolved Network Entropy Analysis Identifies a CTNND1–VAV3 Subnetwork in Gefitinib-Resistant NSCLC},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188409}
}
EUVIMED